dc.contributor.author | McKinnon, L R | |
dc.contributor.author | Kaul, R | |
dc.date.accessioned | 2013-06-27T09:42:34Z | |
dc.date.available | 2013-06-27T09:42:34Z | |
dc.date.issued | 2012-03 | |
dc.identifier.citation | Curr Opin HIV AIDS. 2012 Mar;7(2):195-202. doi: 10.1097/COH.0b013e3283504941 | en |
dc.identifier.uri | http://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/22314505 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/41006 | |
dc.description.abstract | PURPOSE OF REVIEW:
The HIV sexual transmission probability measured in the context of discordant couples appears too low to fuel the HIV pandemic, but these rates are substantially amplified by specific co-factors. The most consistent predictors of transmission are the HIV levels in the blood and genital tract of an infected individual, each of which increases the transmission probability in a dose-dependent manner. In an analogous fashion, we propose that both the quantity and quality of HIV-susceptible target cells in the exposed genital or rectal mucosa may be key predictors of HIV susceptibility.
RECENT FINDINGS:
The absolute number of mucosal CD4+ T cells is increased in several situations that are associated with amplified HIV transmission, particularly during genital infections. In addition, qualitative mucosal T-cell parameters such as immune activation and the expression of the HIV binding molecules CCR5 and/or α4β7 are important determinants of gp120 binding and productive HIV infection. In particular, the Th17 and Th22 cell subsets are enhanced within mucosal compartments and appear to be highly HIV-susceptible.
SUMMARY:
Blockade of specific HIV target cell subsets at the site of exposure, if done in a safe and effective manner, represents an opportunity for new HIV prevention tools. | en |
dc.language.iso | en | en |
dc.publisher | University of Nairobi | en |
dc.title | Quality And Quantity: Mucosal CD4+ T Cells And Hiv Susceptibility | en |
dc.type | Article | en |
local.publisher | Department of Medical Microbiology | en |